SPPI - Spectrum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue-146,444162,556186,830
Cost of Revenue-35,84327,68927,037
Gross Profit-110,601134,867159,793
Operating Expenses
Research Development65,89556,42351,07369,662
Selling General and Administrative77,16786,01888,06497,412
Non Recurring----
Others----
Total Operating Expenses217,927204,230197,985218,399
Operating Income or Loss-89,560-57,786-35,429-31,569
Income from Continuing Operations
Total Other Income/Expenses Net-11,668-14,297-16,807-11,964
Earnings Before Interest and Taxes-89,560-57,786-35,429-31,569
Interest Expense-8,072-9,694-9,212-8,717
Income Before Tax--72,083-52,236-43,533
Income Tax Expense--2,3134062,186
Minority Interest----
Net Income From Continuing Ops--69,770-52,642-45,719
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--69,770-52,642-45,719
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--69,770-52,642-45,719